Akebia Therapeutics Inc (AKBA)
Stock-Based Compensation
$3.23M
Quarterly · Period ending: · USD
AKBA Stock-Based Compensation
Latest reported$3.23Mperiod ending
Latest reported$3.23Mperiod ending
AKBA Quarterly Stock-Based Comp (-$8.54K → $3.23M)
Quarterly stock-based compensation
High-resolution chart · PNG
AKBA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,226,000 | |
| 3,668,000 | |
| 3,199,000 | |
| 3,221,000 | |
| 2,676,000 | |
| 2,187,000 | |
| 1,697,000 | |
| 1,646,000 | |
| 2,072,000 | |
| 2,360,000 | |
| 1,514,000 | |
| 1,824,000 | |
| 3,490,000 | |
| 2,489,000 | |
| 3,041,000 | |
| 3,355,000 | |
| 6,917,000 | |
| 4,536,000 | |
| 4,636,000 | |
| 5,593,000 | |
| 6,514,000 | |
| 5,992,000 | |
| 6,088,000 | |
| 6,592,000 | |
| 6,864,000 | |
| 4,916,000 | |
| 4,934,000 | |
| 2,613,000 | |
| 2,284,000 | |
| 2,094,000 | |
| 12,062,000 | |
| 2,253,000 | |
| 2,493,000 | |
| 2,232,000 | |
| 2,193,000 | |
| 2,152,000 | |
| -907,000 | |
| 5,429,000 | |
| 1,724,000 | |
| 1,628,000 | |
| 1,222,000 | |
| 1,251,000 | |
| 1,328,000 | |
| 1,163,000 | |
| 1,095,000 | |
| 1,128,000 | |
| 885,000 | |
| 1,236,192 | |
| 1,443,944 | |
| 2,444,864 | |
| 1,125,759 | |
| 330,207 | |
| 51,401 | |
| 56,392 | |
| -8,542 |